| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Davide Corleo | Q88840054 |
| Giulio Marchesini | Q46865234 | ||
| Silvio Buscemi | Q57027192 | ||
| P2093 | author name string | Francesco Di Pace | |
| Maria Letizia Petroni | |||
| Angela Satriano | |||
| P2860 | cites work | Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study | Q73570510 |
| Factors influencing the uptake and absorption of carotenoids | Q74597530 | ||
| Retinopathy of prematurity | Q79858093 | ||
| Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin: a double-blind, placebo-controlled study | Q80187947 | ||
| Effects of orlistat therapy on plasma concentrations of oxygenated and hydrocarbon carotenoids | Q80815600 | ||
| Xanthophylls and alpha-tocopherol decrease UVB-induced lipid peroxidation and stress signaling in human lens epithelial cells | Q81073258 | ||
| The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS | Q83211085 | ||
| Effect of 1-year lutein supplementation on macular pigment optical density and visual function | Q84785294 | ||
| Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial | Q85324652 | ||
| Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers | Q86093278 | ||
| A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast | Q86174589 | ||
| Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids | Q86999466 | ||
| Oxidative stress in rats with hyperhomo-cysteinemia and intervention effect of lutein | Q95558842 | ||
| Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. | Q50268024 | ||
| Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: a randomized controlled study. | Q50268928 | ||
| Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. | Q50509680 | ||
| A one year study of the macular pigment: the effect of 140 days of a lutein supplement. | Q50527829 | ||
| Lutein exerts anti-inflammatory effects in patients with coronary artery disease. | Q50634273 | ||
| Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. | Q50704945 | ||
| Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy. | Q50711543 | ||
| Lutein and atherosclerosis: Belfast versus Toulouse revisited. | Q50991353 | ||
| Inhibitory effects of astaxanthin, β-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin on cytochrome P450 enzyme activities. | Q50997537 | ||
| An ecological study of diet and lung cancer in the South Pacific. | Q51210566 | ||
| Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model. | Q51280858 | ||
| Lutein, a carotenoid, suppresses osteoclastic bone resorption and stimulates bone formation in cultures. | Q51365987 | ||
| Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. | Q51528598 | ||
| Toxicity profile of lutein and lutein ester isolated from marigold flowers (Tagetes erecta). | Q51713948 | ||
| The food matrix of spinach is a limiting factor in determining the bioavailability of beta-carotene and to a lesser extent of lutein in humans. | Q52533936 | ||
| A mitochondrial enzyme degrades carotenoids and protects against oxidative stress | Q24308718 | ||
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 | ||
| Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis | Q24569500 | ||
| Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health | Q24602331 | ||
| Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study | Q24619709 | ||
| Carotenoid metabolism in mammals, including man: formation, occurrence, and function of apocarotenoids | Q27001195 | ||
| Location of macular xanthophylls in the most vulnerable regions of photoreceptor outer-segment membranes | Q27690643 | ||
| Macular pigment in retinal health and disease | Q28072398 | ||
| TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD | Q28219450 | ||
| Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 | ||
| Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis | Q30249222 | ||
| Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial | Q30457640 | ||
| Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease | Q30693939 | ||
| Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. | Q31951685 | ||
| Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. | Q33246037 | ||
| Inflammation and its resolution as determinants of acute coronary syndromes | Q33834800 | ||
| Markers of lutein and zeaxanthin status in two age groups of men and women: dietary intake, serum concentrations, lipid profile and macular pigment optical density | Q33847241 | ||
| Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study | Q33860147 | ||
| Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis | Q33864925 | ||
| A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women | Q33875244 | ||
| A prospective study of carotenoid intake and risk of cataract extraction in US men. | Q33875247 | ||
| Nutritional modulation of cataract | Q33900780 | ||
| Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome | Q33953350 | ||
| Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). | Q33977885 | ||
| Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters | Q34213525 | ||
| Lutein: more than just a filter for blue light | Q34215851 | ||
| Antioxidant and prooxidant properties of carotenoids | Q34255896 | ||
| Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q34323879 | ||
| Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. | Q34343037 | ||
| Stereochemistry of the human macular carotenoids. | Q34364881 | ||
| Absorption, metabolism, and transport of carotenoids. | Q40981969 | ||
| Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium | Q40991007 | ||
| Association of carotenoids with risk of gastric cancer: A meta-analysis | Q41333520 | ||
| Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression | Q41462386 | ||
| Lutein intake at the age of 1 year and cardiometabolic health at the age of 6 years: the Generation R Study | Q41472302 | ||
| The association between maternal antioxidant levels in midpregnancy and preeclampsia | Q41543405 | ||
| Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study | Q41654781 | ||
| Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration | Q41845904 | ||
| Association between Dietary Carotenoid Intake and Bone Mineral Density in Korean Adults Aged 30-75 Years Using Data from the Fourth and Fifth Korean National Health and Nutrition Examination Surveys (2008-2011). | Q42368258 | ||
| Lycopene, lutein and beta-carotene as determinants of LDL conjugated dienes in serum | Q43246600 | ||
| A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. | Q43604478 | ||
| Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes | Q43661761 | ||
| Plasma antioxidant vitamins and carotenoids and age-related cataract | Q43802240 | ||
| Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study | Q43897949 | ||
| A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. | Q43932904 | ||
| Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population. | Q43988813 | ||
| Plasma lutein and zeaxanthin and the risk of age-related nuclear cataract among the elderly Finnish population | Q44097855 | ||
| Lutein supplementation improves visual performance in Chinese drivers: 1-year randomized, double-blind, placebo-controlled study | Q44177027 | ||
| Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study | Q44266631 | ||
| Lutein administration to pregnant women with gestational diabetes mellitus is associated to a decrease of oxidative stress in newborns | Q44774121 | ||
| Specific carotenoid intake is inversely associated with the risk of breast cancer among Chinese women. | Q44798823 | ||
| Dietary intake of phytonutrients in relation to fruit and vegetable consumption in Korea | Q44855703 | ||
| Carotenoid, tocopherol, and retinol concentrations in elderly human brain. | Q44885353 | ||
| Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study | Q44964097 | ||
| Role of topical and nutritional supplement to modify the oxidative stress | Q45094706 | ||
| Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project | Q45163501 | ||
| The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy -- a randomised controlled trial | Q45683269 | ||
| Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation | Q45760754 | ||
| Lutein and preterm infants with decreased concentrations of brain carotenoids. | Q45904046 | ||
| A 12-week lutein supplementation improves visual function in Chinese people with long-term computer display light exposure. | Q45935436 | ||
| A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs | Q46296910 | ||
| Lutein protects against β-amyloid peptide-induced oxidative stress in cerebrovascular endothelial cells through modulation of Nrf-2 and NF-κb | Q46455660 | ||
| Effects of lutein on the growth and migration of bovine lens epithelial cells in vitro | Q46532699 | ||
| Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. | Q46568948 | ||
| Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress | Q46765629 | ||
| Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial | Q46815422 | ||
| Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin | Q46858619 | ||
| Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults. | Q47098279 | ||
| Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial | Q47253521 | ||
| Lutein levels in arterial cord blood correlate with neuroprotein activin A in healthy preterm and term newborns: A trophic role for lutein? | Q47382678 | ||
| Mono- and diglycerides improve lutein absorption in healthy adults: a randomised, double-blind, cross-over, single-dose study | Q47450113 | ||
| NrF2/ARE and NF-κB pathway regulation may be the mechanism for lutein inhibition of human breast cancer cell | Q47730603 | ||
| Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | Q47865411 | ||
| Relationship of Lutein and Zeaxanthin Levels to Neurocognitive Functioning: An fMRI Study of Older Adults | Q47969696 | ||
| Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity. | Q48128394 | ||
| Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial | Q48201647 | ||
| Plasma Lutein and Zeaxanthin Are Associated With Better Cognitive Function Across Multiple Domains in a Large Population-Based Sample of Older Adults: Findings from The Irish Longitudinal Study on Aging | Q48251273 | ||
| Focal brain injury increases activin betaA mRNA expression in hippocampal neurons. | Q48636188 | ||
| Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain. | Q49129325 | ||
| Safety assessment of lutein and zeaxanthin (Lutemax 2020): subchronic toxicity and mutagenicity studies. | Q50037630 | ||
| Nutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study. | Q50162479 | ||
| Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer | Q36960453 | ||
| Reinterpretation of the results of a pooled analysis of dietary carotenoid intake and breast cancer risk by using the interval collapsing method | Q37153567 | ||
| Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort | Q37364309 | ||
| Preliminary analysis of the relationship between serum lutein and zeaxanthin levels and macular pigment optical density | Q37395594 | ||
| Parahippocampal Cortex Mediates the Relationship between Lutein and Crystallized Intelligence in Healthy, Older Adults | Q37474988 | ||
| Macular pigment optical density is related to cognitive function in older people | Q37590781 | ||
| Potential role of carotenoids as antioxidants in human health and disease | Q37617691 | ||
| Impact of Mediterranean diet on metabolic syndrome, cancer and longevity | Q37702835 | ||
| Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. | Q38238059 | ||
| The role of complement activation in atherogenesis: the first 40 years | Q38532361 | ||
| Health Effects of Carotenoids during Pregnancy and Lactation. | Q38640978 | ||
| Carotenoid dietary intakes and plasma concentrations are associated with heel bone ultrasound attenuation and osteoporotic fracture risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort | Q38740070 | ||
| Cataracts. | Q38752678 | ||
| Role of oxidative stress and antioxidants in daily nutrition and human health | Q38981950 | ||
| Carotenoid intake and risk of non-Hodgkin lymphoma: a systematic review and dose-response meta-analysis of observational studies | Q39052197 | ||
| Intracellular uptake mechanism of lutein in retinal pigment epithelial cells | Q39097831 | ||
| Inducible nitric oxide synthase: Good or bad? | Q39398858 | ||
| Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration | Q39575237 | ||
| Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation | Q39592849 | ||
| Long-term nutrient intake and 5-year change in nuclear lens opacities | Q39713166 | ||
| Intake of lutein and zeaxanthin differ with age, sex, and ethnicity | Q39843378 | ||
| Lutein prevents the effect of high glucose levels on immune system cells in vivo and in vitro | Q39910623 | ||
| Different molecular organization of two carotenoids, lutein and zeaxanthin, in human colon epithelial cells and colon adenocarcinoma cells | Q40130752 | ||
| Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. | Q40138216 | ||
| Dietary lutein modulates inducible nitric oxide synthase (iNOS) gene and protein expression in mouse macrophage cells (RAW 264.7). | Q40162872 | ||
| Serum carotenoids and colorectal cancer risk: A case-control study in Guangdong, China | Q40163508 | ||
| Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort | Q40962510 | ||
| Lutein Enhances Bone Mass by Stimulating Bone Formation and Suppressing Bone Resorption in Growing Mice. | Q52874644 | ||
| Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: results from a double-blinded, placebo-controlled, crossover study. | Q52909986 | ||
| Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. | Q53121765 | ||
| Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. | Q53129620 | ||
| IL-1 and IL-1 regulatory pathways in cancer progression and therapy. | Q53179726 | ||
| Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. | Q54173070 | ||
| IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases. | Q54249178 | ||
| Crystalline Maculopathy Associated With High-Dose Lutein Supplementation. | Q55311966 | ||
| A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease | Q57268055 | ||
| Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levels | Q57337541 | ||
| Some Dietary Fibers Reduce the Absorption of Carotenoids in Women | Q57419321 | ||
| Dose-Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older | Q59325038 | ||
| Age-related macular degeneration | Q59446738 | ||
| Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration | Q60699438 | ||
| Accelerated bone loss and increased post-fracture mortality in elderly women and men | Q60728882 | ||
| Serum carotenoids and tocopherols and incidence of age-related nuclear cataract | Q63339742 | ||
| Reducing the Genetic Risk of Age-Related Macular Degeneration With Dietary Antioxidants, Zinc, and ω-3 Fatty Acids | Q64461561 | ||
| Plasma β-carotene response in humans after meals supplemented with dietary pectin | Q67485554 | ||
| Analysis of the macular pigment by HPLC: retinal distribution and age study | Q68367274 | ||
| Preliminary identification of the human macular pigment | Q69790666 | ||
| Association of carotenoids with human plasma lipoproteins | Q70650589 | ||
| Effect of beta-carotene supplementation on the concentrations and distribution of carotenoids, vitamin E, vitamin A, and cholesterol in plasma lipoprotein and non-lipoprotein fractions in healthy older women | Q70993957 | ||
| The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas | Q71356050 | ||
| The macular pigment. II. Spatial distribution in primate retinas | Q71356053 | ||
| Gastric acidity influences the blood response to a beta-carotene dose in humans | Q71611071 | ||
| Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses | Q72026161 | ||
| Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group | Q72068439 | ||
| White cell telomere length and risk of premature myocardial infarction | Q73154540 | ||
| Fat-soluble nutrient concentrations in different layers of human cataractous lens | Q73154795 | ||
| Carotenoids and colon cancer | Q73386495 | ||
| A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract | Q34379644 | ||
| Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis | Q34399445 | ||
| Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial | Q34405938 | ||
| Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. | Q34422484 | ||
| Distribution of lutein and zeaxanthin stereoisomers in the human retina | Q34428109 | ||
| Role of lutein supplementation in the management of age-related macular degeneration: meta-analysis of randomized controlled trials | Q34445588 | ||
| Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration | Q34454169 | ||
| Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration | Q34476425 | ||
| Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial | Q34490891 | ||
| Association between higher plasma lutein, zeaxanthin, and vitamin C concentrations and longer telomere length: results of the Austrian Stroke Prevention Study | Q34522202 | ||
| The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview | Q34552999 | ||
| Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. | Q34555413 | ||
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year | Q34582050 | ||
| Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study | Q34633116 | ||
| Carotenoid intake and esophageal cancer risk: a meta-analysis | Q34725729 | ||
| Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study | Q34733171 | ||
| Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative | Q34760523 | ||
| The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients | Q34904372 | ||
| Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis | Q34974714 | ||
| The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d. | Q34979785 | ||
| Carotid-wall intima-media thickness and cardiovascular events | Q35157658 | ||
| Lutein has a protective effect on hepatotoxicity induced by arsenic via Nrf2 signaling. | Q35169978 | ||
| The role of carotenoids in the prevention of human pathologies. | Q35679097 | ||
| Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements | Q35801527 | ||
| Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats | Q35843044 | ||
| The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis | Q35893064 | ||
| Greater serum carotenoid levels associated with lower prevalence of nonalcoholic fatty liver disease in Chinese adults | Q35932583 | ||
| Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 | Q36257030 | ||
| The effects of lutein on respiratory health across the life course: A systematic review | Q36377781 | ||
| Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims | Q36648521 | ||
| Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. | Q36676798 | ||
| Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration | Q36825090 | ||
| Dietary Intake of Lutein and Diabetic Retinopathy in the Atherosclerosis Risk in Communities Study (ARIC). | Q36884076 | ||
| Relationship between Serum and Brain Carotenoids, α-Tocopherol, and Retinol Concentrations and Cognitive Performance in the Oldest Old from the Georgia Centenarian Study | Q36949729 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lutein | Q422067 |
| human eye | Q430024 | ||
| diet | Q474191 | ||
| dietary supplement | Q645858 | ||
| eye disease | Q3041498 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1321 | |
| P577 | publication date | 2018-09-18 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | The Effect of Lutein on Eye and Extra-Eye Health | |
| P478 | volume | 10 |
| Q90207093 | Beneficial effects of vincamine with thioctic acid and lutein on retinal and optic nerve functions in an opaque media |
| Q91924792 | Carotenoids: How Effective Are They to Prevent Age-Related Diseases? |
| Q89477374 | Fruits |
| Q92597098 | Health Benefits of Nut Consumption in Middle-Aged and Elderly Population |
| Q90227960 | Narrow-Banded UVB Affects the Stability of Secondary Plant Metabolites in Kale (Brassica oleracea var. sabellica) and Pea (Pisum sativum) Leaves Being Added to Lentil Flour Fortified Bread: A Novel Approach for Producing Functional Foods |
| Q59130164 | Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target |
Search more.